Unilever PLC $UL Shares Sold by FLC Capital Advisors

FLC Capital Advisors decreased its stake in Unilever PLC (NYSE:UL) by 3.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 11,873 shares of the company’s stock after selling 426 shares during the period. FLC Capital Advisors’ holdings in Unilever were worth $726,000 as of its most recent SEC filing.

Other hedge funds have also modified their holdings of the company. Bank of New York Mellon Corp raised its stake in shares of Unilever by 33.2% during the first quarter. Bank of New York Mellon Corp now owns 934,804 shares of the company’s stock valued at $55,668,000 after purchasing an additional 232,945 shares during the period. Wellington Management Group LLP boosted its stake in shares of Unilever by 13.9% in the first quarter. Wellington Management Group LLP now owns 28,100,442 shares of the company’s stock valued at $1,673,381,000 after purchasing an additional 3,421,054 shares during the period. Stonegate Investment Group LLC grew its holdings in Unilever by 69.7% during the 1st quarter. Stonegate Investment Group LLC now owns 14,282 shares of the company’s stock valued at $850,000 after purchasing an additional 5,867 shares in the last quarter. Russell Investments Group Ltd. increased its stake in Unilever by 65.1% during the 1st quarter. Russell Investments Group Ltd. now owns 232,096 shares of the company’s stock worth $13,821,000 after buying an additional 91,511 shares during the period. Finally, Banco Santander S.A. increased its stake in Unilever by 70.6% during the 1st quarter. Banco Santander S.A. now owns 15,030 shares of the company’s stock worth $895,000 after buying an additional 6,220 shares during the period. 9.67% of the stock is currently owned by hedge funds and other institutional investors.

Unilever Stock Performance

Shares of Unilever stock opened at $63.18 on Monday. Unilever PLC has a 1 year low of $54.32 and a 1 year high of $65.66. The firm’s 50-day simple moving average is $61.51 and its 200-day simple moving average is $61.69. The firm has a market cap of $155.03 billion, a PE ratio of 18.10, a price-to-earnings-growth ratio of 4.75 and a beta of 0.40.

Unilever Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, September 12th. Stockholders of record on Friday, August 15th were given a $0.5175 dividend. This represents a $2.07 annualized dividend and a dividend yield of 3.3%. The ex-dividend date was Friday, August 15th. This is a positive change from Unilever’s previous quarterly dividend of $0.52. Unilever’s payout ratio is 59.31%.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. CICC Research assumed coverage on Unilever in a research note on Thursday, August 21st. They set an “outperform” rating for the company. Zacks Research downgraded Unilever from a “strong-buy” rating to a “hold” rating in a report on Thursday. Weiss Ratings restated a “buy (b)” rating on shares of Unilever in a research note on Wednesday, October 8th. Finally, Jefferies Financial Group restated an “underperform” rating on shares of Unilever in a report on Sunday, August 3rd. Two investment analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating, three have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $73.00.

Unilever Profile

Unilever PLC operates as a fast-moving consumer goods company in the Asia Pacific, Africa, the Americas, and Europe. It operates through five segments: Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products consist of the vitamins, minerals, and supplements.